描述

Clinical trial data comparing bowel movement frequency in infants receiving fructooligosaccharides (FOS) versus placebo. The randomized, double-blind study assessed FOS effectiveness in treating constipation during the first year of life.

Figure 1

Chart

Source Paper

Randomized, Double-Blind, Placebo-Controlled Parallel Clinical Trial Assessing the Effect of Fructooligosaccharides in Infants with Constipation.

Nutrients (2018)

PMID: 30388751

DOI: 10.3390/nu10111602

Cite This Figure

![Figure 1: Clinical trial data comparing bowel movement frequency in infants receiving fructooligosaccharides (FOS) versus placebo. The randomized, double-blind study assessed FOS effectiveness in treating constipation during the first year of life.]()

> Source: Daniela da Silva Souza et al. "Randomized, Double-Blind, Placebo-Controlled Parallel Clinical Trial Assessing t." *Nutrients*, 2018. PMID: [30388751](https://pubmed.ncbi.nlm.nih.gov/30388751/)

<figure>
  <img src="" alt="Clinical trial data comparing bowel movement frequency in infants receiving fructooligosaccharides (FOS) versus placebo. The randomized, double-blind study assessed FOS effectiveness in treating constipation during the first year of life." />
  <figcaption>Figure 1. Clinical trial data comparing bowel movement frequency in infants receiving fructooligosaccharides (FOS) versus placebo. The randomized, double-blind study assessed FOS effectiveness in treating constipation during the first year of life.<br>  Source: Daniela da Silva Souza et al. "Randomized, Double-Blind, Placebo-Controlled Parallel Clinical Trial Assessing t." <em>Nutrients</em>, 2018. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30388751/">30388751</a></figcaption>
</figure>

描述

Figure 1

Source Paper

Cite This Figure

相关证据